Thomas Timbie - Nov 16, 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Director
Signature
/s/ Lisa Taylor as Attorney-in-fact for Thomas Timbie
Stock symbol
TMCI
Transactions as of
Nov 16, 2022
Transactions value $
-$1,006,900
Form type
4
Date filed
11/18/2022, 07:00 PM
Previous filing
Aug 17, 2022
Next filing
Nov 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale -$1.01M -50K -3.45% $20.14 1.4M Nov 16, 2022 Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001 F1, F2
holding TMCI Common Stock 2.3K Nov 16, 2022 Direct F3
holding TMCI Common Stock 385K Nov 16, 2022 Pamela Timbie and Thomas Timbie as Trustees of the PAMELA F TIMBIE REV TRUST
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.760 to $20.370 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date.